Clinical Trial Update: Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on allogeneic adipose tissue-derived stem cells for Alzheimer’s disease in Phase 1/Phase 2; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Allogeneic adipose tissue-derived stem cells (adipose tissue-derived stem cells (allogeneic))

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING